First, Esaote came to the aid of China, a country with which the company has strong connections, given that their shares are owned by a group of six Chinese industrial (Wandong, Yuwell, Kangda) and financial companies (Yunfeng, Shanghai Ftz, Tianyi).

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

We have a duty to develop a complete understanding of the limits within which we can carry out our production activities. Today, it is within those limits that we can grow and do more.

In these days we are facing two epidemic events. The first one is the new coronavirus that is putting many countries in the world in great difficulty.

Rome, February 14th, 2020 - Esaote, an Italian company among the world leaders in the field of medical diagnostic imaging systems, is the Ducati Team's Official Partner for the 2020 season. The collaboration agreement between the two brands was...

Genoa, February 6th 2020 - BNP Paribas Leasing Solutions, European leader in asset finance, and Esaote, one of the world's leading manufacturers of medical diagnostic systems, announced today the signature of an international partnership.

Franco Fontana new CEO, Eugenio Biglieri new Chief Operating Officer. A new Board of Directors has been appointed.

Genoa, 13 May 2019 - The Shareholder’s Meeting of Esaote S.p.A. – a leading Company in the sector of diagnostic imaging - held in...

April 22, 2019 (Fishers, IN, USA) - Esaote, one of the world’s leading manufacturers of diagnostic ultrasound systems and probes, in the market for more than 30 years, introduces the new MyLab^™X5 ultrasound system in the United States. The new...

March 26th - Genoa, Italy – “Never Stop Seeing the Unseen": this is the title of the new communications campaign of Esaote, an Italian company among the world leaders in diagnostic imaging, which for over thirty years has been designing, creating and...

FAST study demonstrates high diagnostic accuracy of CAAS vFFR and received USA 510(k) market clearance.

Esaote SpA announces the completion of the acquisition of its share capital by a Consortium of leading Chinese investors.

New investor is a consortium of leading chinese healthcare companies and financial sponsors.

26th August 2017 [Barcelona, Spain] ‐ Esaote has the pleasure to support the ESC 2017, European Cardiovascular Congress (Barcelona, Spain ‐ August 26th‐30th)

Esaote presents his experience on the Chinese market in the meeting organized by the Liguria Region with a delegation from Guangdong.

Ebit (Esaote Group) and Siemens Healthineers signed an important partnership to resell Suitestensa, the Ebit software dedicated to cardiology

Today Esaote S.p.A. (www.esaote.com) opened a new plant for the company’s research and production of dedicated MRI systems in Genoa Multedo

At the historical headquarter in Via di Caciolle, Florence – Esaote S.p.A., leader in the biomedical electronics sector, inaugurated its new Centre of Excellence for Probes

Chicago, Illinois 27 November 2016 - Esaote, one of the world leaders in the manufacturing of medical imaging equipment, introduces the MyLab^™Eight Ultrasound System* at RSNA 2016...

Chicago, Illinois 27 November 2016 - Esaote, one of the world leaders in the manufacturing of medical imaging equipment, introduces the MyLab^™Six CrystaLine at the Radiology Society of North America...

North Wales Glan Clwyd Hospital is the first NHS Hospital to invest in a weight-bearing MRI scanner...

INDIANAPOLIS, – Esaote North America, Inc. announced today that Larry Dentice...

Esaote receives FDA clearance to market and sell its Virtual Navigator fusion...

Washington DC, March 28, 2014 – At the 63rd Annual Scientific Session of the American College of Cardiology, Esaote is demonstrating new CrystaLine imaging...

To better prepare cardiovascular ultrasound students to compete and thrive in the evolving healthcare environment, Oregon Institute of Technology (Oregon Tech) ...